Insulet (PODD)

• Market cap: $23.3B
• 1 day: 5.84%
• 5 days: -0.08%
• 1 month: 0.67%
• 3 months: 1.01%
• 6 months: 2.06%
• Year to date: 28.94%
• 1 year: 26.4%
• 5 years: 24.55%
• 10 years: 852.46%
• Sector: Healthcare
• Industry: Medical Devices

About: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Employees: 3,900